Multinational pharmaceutical companies are expressing disapproval on the report of Phase 4 clinical trial adverse reactions

Multinational pharmaceutical companies are expressing disapproval on the report of Phase 4 clinical trial adverse reactions. They insist that it is difficult to follow the same rules of Ministry of Food and Drug Safety, because there's a difference between domestic and international standard.

On May 27, Ministry of Food and Drug Safety held the briefing session about safety management of medic...